Melissa Visit 1: Use of biologic markers in diagnosing and treating IBD

Title:

Melissa Visit 1: Use of biologic markers in diagnosing and treating IBD

Topic: Gastroenterology
Relevant Terms: Pediatric Gastroenterology, Inflammatory Bowel Disease, Biomarkers
Primary Audience: Clinicians and health care providers who treat children and adolescents with Inflammatory Bowel Disease.
Launch Date: 18-Feb-14
Credits: AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Pediatric Inflammatory Bowel Disease

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Name the biologic makers associated with IBD 
  2. Utilize the predictive value of biologic markers 
  3. Evaluate the clinical utility of biologic markers 
  4. Decide to use or not use biologic markers as part of the diagnostic evaluation 
  5. Decide to use or not use biologic markers as predictors of complications of IBD 

    Faculty

    David Ziring, MD 
    Assistant Professor
    UCLA David Geffen School of Medicine
    Director, Pediatric IBD Center
    Mattel Children's Hospital UCLA                
    Division of Pediatric Gastroenterology, Hepatology, and Nutrition
    Los Angeles, CA

    Dr. Ziring receives an honorarium from Salix Pharmaceuticals. He does not plan to discuss unlabeled or investigational uses of a commercial product.

    Benjamin D. Gold, MD, FACG, FAAP
    Attending Physician 
    Children's Center for Digestive Health Care
    Pediatric Gastroenterology, Hepatology and Nutrition 
    Children's Healthcare of Atlanta
    Atlanta, Georgia 

    Dr. Gold receives Grant/Research support from Takeda Development Center Americas Inc; and receives honoraria from Astra Zeneca, Janssen/Johnson and Johnson, Nestle USA, Nutricia, Inc., Prometheus, Mead Johnson, Takeda Development Center Americas Inc. and Pfizer. He does not plan to discuss unlabeled or investigational uses of a commercial product.

    We would like to thank The Louis and Rachel Rudin Foundation and Nutricia Advanced Medical Nutrition for their support.

    This educational activity is sponsored by independent medical education grants from AbbVie, Janssen Biotech, Prometheus, Salix, and Shire.

     
    Jointly sponsored by:
     
        



    Accreditation Statement
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Partners HealthCare and The Pediatric Inflammatory Bowel Disease Foundation, Inc. Partners is accredited by the ACCME to provide continuing medical education for physicians."
     
    Partners HealthCare System designates this enduing material activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
     
    Disclosure Statement
    In accord with the disclosure policy of Partners HealthCare System as well as guidelines of the Accreditation Council for Continuing Medical Education (ACCME), planners, speakers and anyone who may have an influence on the content of the activity have been asked to disclose any relationship they or their spouse/partner have to companies producing pharmaceuticals, medical equipment, devices, etc. that may be germane to the content of their presentation. Such disclosure is not intended to suggest or condone bias, but provides participants with information that might be of potential importance to their evaluation of a given presentation.
     
    RESOLUTION OF CONFLICTS OF INTEREST (COI)
    Partners HealthCare System has implemented a process to resolve potential COIs for this CME activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public. 
     
    The following planners and/or their spouse/partner have reported no relevant financial relationship with a commercial interest:
     
    Jess L. Kaplan, MD
    PLANNER
    Department of Pediatric Gastroenterology at Massachusetts General Hospital for Children.
     
    Dr. Kaplan has nothing to disclose with regard to commercial support. He indicates that he does not plan to discuss unlabeled or investigational uses of a commercial product.
     
    Nina L. Gluchowski, MD
    PLANNER
    Chief Resident in Pediatrics at Massachusetts General Hospital for Children.
    Dr. Gluchowski has nothing to disclose with regard to commercial support. She indicates that she does not plan to discuss unlabeled or investigational uses of a commercial product.
     
    Christopher J. Moran, MD
    PLANNER
    Instructor of Pediatrics, Harvard Medical School.
     
    Dr. Moran has nothing to disclose with regard to commercial support. He indicates that he does not plan to discuss unlabeled or investigational uses of a commercial product.
     
    Kriston A. Ganguli, MD
    PLANNER
    Department of Pediatric Gastroenterology at Massachusetts General Hospital for Children.
     
    Dr. Ganguli has nothing to disclose with regard to commercial support. She indicates that she does not plan to discuss unlabeled or investigational uses of a commercial product.
     
    Eugenica Kochergin, MS
    PLANNER
    Pediatric IBD Foundation Program Director, CME Project Administrator.
     
    Ms. Kochergin has nothing to disclose with regard to commercial support.
     
    The following planners and/or their spouse/partner have reported a relevant financial relationship with a commercial interest:
     
    Harland S. Winter, MD
    CME COURSE DIRECTOR
    Director, Pediatric Inflammatory Bowel Disease Center, MassGeneral Hospital for Children.
     
    Dr. Winter receives Grant/Research support from Autism Research Institute, Janssen, Nutricia, Pediatric IBD Foundation, Prometheus Laboratories, and UCB Pharma. He serves as a consultatnt for Janssen, Pediatric IBD Foundation, and Prometheus Laboratories. He does not plan to discuss unlabeled or investigational uses of a commercial product.
     
    David Ziring, MD
    FACULTY
    Director, Pediatric IBD Center, Mattel Children's Hospital UCLA 
     
    Dr. Ziring receives Grant/Research support from Salix Pharmaceuticals. He does not plan to discuss unlabeled or investigational uses of a commercial product.
     
    Benjamin D. Gold, MD, FACG, FAAP
    FACULTY
    Children's Center for Digestive Health Care
     
    Dr. Gold receives Grant/Research support from Takeda Pharmaceuticals;and  is a consultant for Astra Zeneca, Centocor, Johnson and Johnson, Nestle USA, Nutricia, Inc., and Pfizer. He does not plan to discuss unlabeled or investigational uses of a commercial product.

    Disclaimer Statement
    Disclaimer
    THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NON INFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. 

    Privacy Policies
    BU Privacy Policy http://www.partners.org/Notices/Web-Privacy-Statement.aspx
     
    Peds IBD http://www.pedsibd.org/ibd_portal/terms_of_use.pdf
             
    Course Viewing Requirements
    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Mozilla 1.4+ for Windows, Mac, or Linux
    Firefox 3.5+ for Windows, Mac, or Linux
    Safari 4.0+ for Mac

    For CME questions: email cme@bu.edu or visit website www.bu.edu/cme
     
    Partners Healthcare CME Course E020114

    To claim credit, complete the module and the post-test with a score of at least 70%. An electronic certificate will be generated on the last page of the module. Click the Download Certificate button or choose to have the certificate sent to your email address. 

    Jointly sponsored by: